Trademark: YULINXUS 2283441
Word
YULINXUS
ID
2283441
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
23 February 2022
Registration Date
23 February 2022
Renewal Date
23 February 2032
Owner(s)
Service
Goods and Services:
Class 5:
Pharmaceuticals for use in the prevention and treatment of neurologic, genetic, psychologic, and psychiatric diseases and disorders.
Pharmaceuticals for use in the prevention and treatment of neurologic, genetic, psychologic, and psychiatric diseases and disorders.
Class 35:
Promoting awareness of patient support offerings for neurologic, genetic, psychologic, and psychiatric diseases and disorders; medical referrals.
Promoting awareness of patient support offerings for neurologic, genetic, psychologic, and psychiatric diseases and disorders; medical referrals.
Class 42:
Scientific and industrial biotechnological and biomedical research; chemical, biochemical and molecular biological analyses; providing medical and scientific research information in the field of pharmaceuticals and clinical trials.
Scientific and industrial biotechnological and biomedical research; chemical, biochemical and molecular biological analyses; providing medical and scientific research information in the field of pharmaceuticals and clinical trials.
Class 44:
Medical consulting with respect to neurologic, genetic, psychologic, and psychiatric diseases and disorders, including Rett syndrome and its identification and treatment; providing online information for health care providers, caregivers, and patients in the field of neurologic, genetic, psychologic, and psychiatric diseases and disorders; medical informational support services, namely, providing information about the benefits of diagnostic tools, medical information regarding disease diagnosis, identification, treatment, and management, and healthcare-related information to patients, caregivers, and healthcare professionals all related to neurologic, genetic, psychologic, and psychiatric diseases and disorders; medical testing, namely, in vitro and in vivo preclinical testing of potential drugs; consultation related thereto.
Medical consulting with respect to neurologic, genetic, psychologic, and psychiatric diseases and disorders, including Rett syndrome and its identification and treatment; providing online information for health care providers, caregivers, and patients in the field of neurologic, genetic, psychologic, and psychiatric diseases and disorders; medical informational support services, namely, providing information about the benefits of diagnostic tools, medical information regarding disease diagnosis, identification, treatment, and management, and healthcare-related information to patients, caregivers, and healthcare professionals all related to neurologic, genetic, psychologic, and psychiatric diseases and disorders; medical testing, namely, in vitro and in vivo preclinical testing of potential drugs; consultation related thereto.